What can we help you find?

Leading the way in transplantation

Filter results for:

ESOT Roadmap for Advanced Therapy Medicinal Products in Transplantation: Navigating Regulatory Challenges to Enhance Access and Care

Our latest publication is a position paper from the ESOT Advanced Therapy Medicinal Products (ATMP) task force. Named “ESOT Roadmap for Advanced Therapy Medicinal Products in Transplantation: Navigating Regulatory Challenges to Enhance Access and Care“, the document discusses ways to address hurdles and effectively improve access and care in this field of medicine.  ATMP therapies

The molecular landscape of kidney rejection

In the latest issue of Transplant International, Cortes Garcia and colleagues (France) examined bulk RNA sequencing of kidney biopsies. They identified novel genes associated with antibody-mediated rejection and T cell-mediated rejection, which could provide a new source of targets for drug design and repurposing.

Treating Split Livers with HOPE

In the latest issue of Transplant International, Rossignol and colleagues (Lyon, France) studied the impact of hypothermic oxygenated perfusion on ex situ split grafts (HOPE-Split) in paediatric liver transplantation. Compared with static cold storage ex situ partial grafts, HOPE-Split had significantly shorter cold ischaemia times, less post-reperfusion syndrome and a lower ischaemia-reperfusion injury score. The

ESOT at Informal Meeting of the National Competent Authorities for Organ Donation and Transplantation in Budapest, Hungary

ESOT (European Society for Organ Transplantation) was honoured to participate in the Informal Meeting of the National Competent Authorities for Organ Donation and Transplantation. This significant event was hosted by the Hungarian Presidency of the Council of the European Union in Budapest on 10 July 2024. The meeting gathered policymakers and experts to discuss advancements